Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 218 results for "medicines for malaria venture"

Medicines for Malaria Venture signs collaboration with Cipla and Strides Arcolab for rectal artesunate
Pharma Letter

MMV inks collaboration with Cipla and Strides Arcolab

Medicines for Malaria Venture (MMV) signs collaboration agreements with two Indian pharmaceutical companies, Cipla Limited and Strides Arcolab Limited for the development of rectal artesunate for pre-referral treatment of children with severe ... Equity Bulls, 1 month ago


Medicines and Malaria Venture (MMV) has signed agreements with Cipla and Strides Arcolab to develop rectal artesumate. The company expects to have the product pre-qualified by the World Trade Organisation (WTO) by 2016. MMV is involved in ...
 4 Traders1 month ago MMV inks pact with Cipla, Strides on anti-malarial  Hindu Business Line2 months ago

Cipla Ltd, Strides Arcolab signs collaboration agreements with Medicines for Malaria Venture

MUMBAI: Pharma firms Cipla Ltd and Strides Arcolab today signed collaboration agreements with Switzerland-based Medicines for Malaria Venture (MMV) for the development of rectal artesunate for pre-referral treatment of children with severe malaria. ...
 Economic Times2 months ago Cipla, Strides Arcolab Signs Collaboration Agreements with MMV  NDTV Profit2 months ago

New malaria drug unleashes an immune system assault on infected cells

Howard Hughes Medical Institute investigator Joseph DeRisi is working on a new malaria treatment that makes infected red blood cells an inviting target for the human immune system. And the team behind the effort is ramping up a human safety study in ...
 Fierce Biotech Research1 month ago Experimental Antimalaria Drug Induces the Immune System to Destroy Infected Red Blood Cells  Biotech Daily1 month ago

Pharmaceutical Newsletter - December 22 to 26, 2014

Top News Cabinet approves 100% FDI in medical devices The Union Cabinet chaired by the Prime Minister Narendra Modi gave its approval to amend the existing Foreign Direct Investment (FDI) policy in the Pharmaceutical Sector to create carve out ...
 India Infoline1 month ago

Rameswaram fishermen on malaria study radar

Comment · print · T T T+· T- The Rameswaram fishermen, who have been facing several uncertainties while fishing in the seas, are battling another major challenge — malaria — which experts say needs immediate attention. It has ...
 The Hindu1 month ago

Scientists record success in malaria elimination with new compound, good gut bacteria

• Agent prevents prostate cancer growth, spread in animal studies SCIENTISTS have recorded two major breakthrough in their quest to eliminate malaria with the discovery of a promising anti-malarial compound tricks the immune system to rapidly ...
 The Guardian Nigeria1 month ago Nigeria: Scientists Record Success in Malaria Elimination With New Compound, Good Gut Bacteria  AllAfrica.com1 month ago

Oxford's Skoll Scholars addressing some of Africa's most critical social problems

via PRWEB - Africa is a global hub for entrepreneurship with impactful ventures leading social and economic progress throughout the continent. The individuals founding and developing African ventures bring energy, commitment and dedication to their ...
 Individual.com2 months ago

'Partnering for Cures': Medical innovators team up to treat deadly diseases

That was the theme when medical thought leaders converged on New York City recently for the Faster Cures Center of the Milken Institute's Partnering for Cures conference where Fox News own Dr. Manny Alvarez was a panel moderator. The event brings ...
 FOXNews.com2 months ago

ISMB assessment enables recruitment of 2-5 year olds into Phase IIb trial for next-generation single-dose cure for malaria

An Independent Safety Monitoring Board (ISMB) has recommended that recruitment of patients aged 2-5 years can begin for the ongoing Phase IIb safety and efficacy trial of a single dose of the antimalarial combination therapy OZ439 (artefenomel, a ...
 Medical News Today1 week ago Africa: Independent Safety Monitoring Board Assessment Enables Recruitment of 2-5 Year Olds Into Oz439/Pqp Phase Iib Trial  AllAfrica.com1 week ago Independent Safety Monitoring Board Assessment Enables Recruitment of 2-5 Year Olds Into Oz439/Pqp Phase Iib Trial [press release]  Individual.com1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less